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Background: Increased risk of oxycodone (oxy) dependency during pregnancy has
been associated with altered behaviors and cognitive deficits in exposed offspring.
However, a significant knowledge gap remains regarding the effect of in utero and
postnatal exposure on neurodevelopment and subsequent behavioral outcomes.
Methods: Using a preclinical rodent model that mimics oxy exposure in utero (IUO)
and postnatally (PNO), we employed an integrative holistic systems biology approach
encompassing proton magnetic resonance spectroscopy (1H-MRS), electrophysiology,
RNA-sequencing, and Von Frey pain testing to elucidate molecular and behavioral
changes in the exposed offspring during early neurodevelopment as well as adulthood.
Results: 1H-MRS studies revealed significant changes in key brain metabolites in
the exposed offspring that were corroborated with changes in synaptic currents.
Transcriptomic analysis employing RNA-sequencing identified alterations in the
expression of pivotal genes associated with synaptic transmission, neurodevelopment,
mood disorders, and addiction in the treatment groups. Furthermore, Von Frey analysis
revealed lower pain thresholds in both exposed groups.
Conclusions: Given the increased use of opiates, understanding the persistent
developmental effects of these drugs on children will delineate potential risks associated
with opiate use beyond the direct effects in pregnant women.
Keywords: oxycodone, electrophysiology, RNA-sequencing (RNA-Seq), Von Frey, proton magnetic resonance
spectroscopy (1H-MRS)
INTRODUCTION
Over the last few years, the increasing trend in opioid abuse has become a major public health
crisis across the globe. As a result, this steep increase in abuse of prescription opioids, which
include both licit and illicit opioids, has resulted in the opioid epidemic (Volkow and McLellan,
2016). Whilst this epidemic has traversed different groups in the society, pregnant women are a
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particularly vulnerable group since they are prescribed opioids
such as morphine, buprenorphine, and methadone, all of
which have been shown to cross the placenta (Gerdin et al.,
1990; Nanovskaya et al., 2002, 2008), potentially impacting the
developing fetus. Limited data exist regarding the effects of in
utero (IUO) or postnatal (PNO) exposure to oxycodone (oxy),
however. Oxy is prescribed for multiple types of pain and can
bind to mu- and kappa-opioid receptors (Kim, 2017). Oxy easily
passes through the blood-brain barrier, thus allowing higher
concentrations to accumulate in the brain (Okura et al., 2008,
2015; Chaves et al., 2017), subsequently contributing to its
analgesic properties and risk for dependency and addiction.
Several studies (Byrnes and Vassoler, 2018) have been
conducted with rodent models to investigate the detrimental
effects of gestational opioid use on neurodevelopment of
the offspring, but a gap in knowledge exists regarding the
effects of IUO or PNO oxy exposure on synaptogenesis.
We have previously identified novel miRNA signatures
related to neurodevelopment contained within brain-derived
extracellular vesicles of PNO and IUO offspring (Shahjin et al.,
2019), and our current study aims to investigate metabolic,
synaptic, molecular, and behavioral alterations in these exposed
offspring. Using a Sprague Dawley rat model previously
established by our labs (Shahjin et al., 2019; Odegaard et al.,
2020), we employed proton magnetic resonance spectroscopy
(1H-MRS) to measure biochemical changes of main brain
metabolites in the hippocampus. Additionally, we identified
synaptic alterations in the hippocampus through the use
of electrophysiology experiments. Further, RNA-sequencing
(RNA-seq) was conducted on tissue RNA isolated from the
prefrontal cortex (PFC) to determine changes in gene expression,
particularly in genes related to neurodevelopment, disease states,
and mood disorders. The hippocampus and the PFC are key
regions involved in substance abuse disorders and the negative
emotional state associated with withdrawal (Koob, 2020);
indeed, systemic opioid exposure has been shown to attenuate
hippocampal afferent-driven activity in the PFC (Giacchino and
Henriksen, 1998). For these reasons, we have investigated both
regions in this study to identify alterations in either area of the
brain during the early developmental period spanning from
post-natal day 14 (P14) to P17, which corresponds with peak
synaptogenesis (Semple et al., 2013). In our final experiments,
we employed Von Frey tests to elucidate any lasting impacts of
early-life oxy exposure on pain thresholds. The comprehensive
and systematic approach used in this study allows for thorough
research into pre- and post-natal oxy abuse, a critical step in




Male and female Sprague Dawley rats were obtained from
Charles River Laboratories Inc. (Wilmington, MA, USA) and
group housed in a 12 h light–dark cycle and fed ad libitum.
The total number of animals used for this study can be found
in Supplementary Table 1. All procedures and protocols were
approved by the Institutional Animal Care and Use Committee
of the University of Nebraska Medical Center (UNMC) and
conducted in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Oxycodone Treatment
The development of the IUO treatment paradigm was adapted
from a previously published study (Davis et al., 2010), and the
overall treatment paradigm previously established in our lab was
followed (Shahjin et al., 2019; Odegaard et al., 2020). Briefly,
nulliparous female (64–70 days of age) Sprague Dawley rats were
treated with oxycodone HCl (Sigma Aldrich, St. Louis, MO)
dissolved in saline or saline vehicle via oral gavage. An ascending
dosing procedure was used wherein doses of 10 mg/kg/day of
oxy were orally-gavaged for 5 days followed by a 0.5 mg/kg/day
escalation for 10 days until reaching a final dose of 15 mg/kg/day,
after which females were mated with proven male breeders.
The treatment regimen continued throughout mating, gestation,
and parturition until weaning (P21). For the PNO paradigm,
dams were orally-gavaged with 15 mg/kg/day of oxy only after
parturition until weaning. Upon weaning of the pups, dams were
euthanized by isoflurane overdose followed by decapitation using
a guillotine.
MRI/MRS Acquisitions
P17 pups were used for in vivo localized 1H-MRS imaging
of the hippocampus. Animals were anesthetized by inhalation
of 1–1.5% isoflurane in 100% oxygen and maintained 40–80
breaths/minute. The duration of a study for a single animal
was about 1 h. MRI and 1H-MRS data were obtained using a
Bruker R© Biospin 7 Tesla/21 cm small animal scanner (Bruker,
Billerica, MA), operating at 300.41 MHz, using a laboratory-
built 22mm diameter quadrature birdcage volume coil. All
first- and second-order shim terms were first automatically
adjusted in the volume-of-interest (VOI) using MAPSHIM R©
(Bruker, Billerica, MA), with a final shim performed manually
to achieve a water line width of 10–15Hz. The water signal
was suppressed by variable power radiofrequency pulses with
optimized relaxation delays (VAPOR) (Tkác et al., 1999). MR
images were acquired for anatomical reference using a multi-slice
rapid acquisition with relaxation enhancement (RARE) sequence
(Effective echo time (TE) = 36ms, Rare Factor = 8, repetition
time (TR) = 4,200ms, Number of Averages (NA) = 2, Scan
Time = 3m 21 s; FOV = 20 × 20 mm2, Matrix Size = 256 ×
256, Spatial Resolution = 0.078125 × 0.078125 mm2, Number
of Slices = 29, Slice Thickness = 0.5mm). 1H MRS data
sets were obtained using semiLASER localization with timing
parameters (TE/TR = 40/4,000ms, 576 averages, 2,048 points)
from a 2 × 5.187 × 1.557 mm3 (16.15 µl) VOI located in
the hippocampus. Pulse types and specifications: Excitation:
hermite 90, duration = 0.7ms, bandwidth = 5,400Hz; 1st
and 2nd Refocusing: hyperbolic secant, duration = 4ms,
bandwidth = 9484.5Hz. The acquisition time was 38:24min
per data set. All pulses were applied with a frequency offset
of −600Hz to center the pulse bandwidth between Creatine
(CRE) and N-Acetyl Aspartate (NAA). For the water suppression
module, the spoiler strength matrix was calculated automatically.
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Spoiler strength was 35%; spoiler duration was 1.5ms. For
each experiment, one data set was acquired without water
suppression to be used as the water concentration reference
for the quantitation process. Unsuppressed water spectra were
obtained with identical metabolite spectra parameters except
for the following: TR = 10,000ms, NA = 1, and Receiver
Gain = 64. One 64 average (for quality assessment) plus four
128-average data sets were acquired formetabolite measurements
using a combination of VAPOR (Tkác et al., 1999) scheme for
water suppression.
Model parameters and constraints for quantification were
generated using spectra from phantoms (n = 14) for the
following metabolites: Alanine (ALA), Aspartate (ASP), Gamma-
Aminobutyric acid (GABA), Glucose (GLC), Glutamine (GLN),
Glutamate (GLU), Glycine (GLY), Lactate (LAC), Myo-inositol
(MYO), Phosphorylcholine (PC), Taurine (TAU), total choline
(tCHO), CRE, and NAA. Phantoms of each metabolite were
prepared in pH 7.5 phosphate buffer (100mM) and contained
3-(trimethylsilyl)-1-propane-sulfonic acid and sodium formate as
chemical shift and phasing references. Spectra for eachmetabolite
at known concentrations were acquired using semiLASER
(Wijnen et al., 2010) sequences at 40ms TE, maintaining the
phantom at 38◦C with a circulating water jacket during spectral
acquisition. The set of metabolite spectra formed a metabolite
basis set, which was used as prior-knowledge in the quantification
process. In all groups, n= 6 for all metabolites except LAC (IUO
n= 4).
Electrophysiology
Coronal hippocampal brain slices were prepared from P17
animals (n = 6 per group) using the “protected recovery”
method (Ting et al., 2014). Briefly, rats were euthanized by CO2
asphyxiation and decapitated; brains were rapidly dissected into a
slush of artificial cerebrospinal fluid (ACSF) containing (in mM)
124 NaCl, 2.5 KCl, 1.25 NaH2PO4, 24 NaHCO3, 12.5 glucose, 2
CaCl2, and 2 MgSO4 and continuously bubbled with a mixture
of 5% CO2 and 95% O2. The cerebellum was removed with a
razor blade, and the brain was affixed to the cutting chamber
using cyanoacrylate glue. Two hundred and fifty micron-thick
coronal brain sections through the hippocampus were cut using a
vibrating microtome (Leica VT1000S) and hemisected into right
and left halves through the midline before being transferred to
a net submerged in an N-methyl-D-glucamine (NMDG)-based
ACSF composed of (in mM) 92 NMDG, 2.5 KCl, 1.25 NaH2PO4
30 NaHCO3, 20 HEPES, 0.5 CaCl2, 10 MgSO4, 2 thiourea, 5 L-
ascorbic acid, and 3 Na-pyruvate, warmed to∼30◦C and bubbled
with 5% CO2 and 95% O2. After a 10 to 15min incubation
in the NMDG ACSF, slices were transferred to a chamber
containing room temperature ACSF and allowed to recover for
1 h before beginning patch clamp experiments. Reagents were
purchased from Thermo Fisher Scientific (Waltham, MA) unless
noted otherwise.
For whole-cell recording, slices were positioned in a recording
chamber on an upright fixed-stage microscope (Olympus
BX51WI) and superfused by a gravity-fed system with ACSF
warmed to 29–31◦C using an in-line solution heater at
approximately 4 mL/min. The ACSF was supplemented with
60µM picrotoxin. A concentric bipolar stimulating electrode
was positioned in the stratum radiatum to stimulate Schaffer
collateral axons using a 0.1ms current delivered at 0.1Hz from
an isolated pulse stimulator (A-M Systems Model 2100). CA1
pyramidal neurons were targeted for whole-cell recording with
patch pipettes pulled from thin-walled borosolicate glass on a
Sutter P-1000 micropipette puller. The patch pipettes had a
resistance of 5–8 M when filled with a solution containing (in
mM) 120 Cs-methanesolfonate, 10 HEPES, 8 TEA-Cl, 5 ATP-
Mg, 0.5 GTP-Na2, 5 phosphocreatine, and 0.5 EGTA (pH= 7.35,
osmolality = 282 mOsm). Reported voltages are corrected for a
10mV liquid junction potential. The intensity-response profile
of the evoked excitatory post-synaptic currents (EPSCs) for each
cell was determined by the average of 3–10 responses obtained
at each stimulus strength (50–225 µA). The AMPA/NMDA ratio
was measured as the ratio of the peak of the inward EPSC
recorded at −70mV to the outward EPSC amplitude at 50ms
post-stimulus at a holding potential of+40mV.Miniature EPSCs
(mEPSCs) were recorded in the absence of stimulus and were
detected and analyzed using MiniAnalysis (Synaptosoft). mEPSC
frequency for each recorded cell was determined as the median of
the instantaneous frequencies of all detected events for that cell.
Due to variability in the number of cells patched and recorded,
respective samples sizes are provided in Figure 2.
Total RNA Extraction, Quality Control,
Library Preparation, and RNA-Seq
Total RNA from prefrontal cortex (PFC) tissue was isolated
from the randomly selected pups (n = 6) from each treatment
group at P14 using the Direct-Zol RNA kit (Zymo Research,
CA, USA) based on the manufacturer’s protocol. Samples were
sent to UNMC’s Next Generation Sequencing (NGS) core.
RNAseq libraries were generated beginning with 1 ug of total
RNA from each sample using the TruSeq V2 RNA sequencing
library kit from Illumina following recommended procedures
(Illumina Inc., San Diego, CA). Resultant libraries were assessed
for size of insert by analysis of an aliquot of each library on
a BioAnalyzer instrument (Agilent Technologies, Santa Clara,
CA). Each library contained a unique indexing identifier barcode
allowing the individual libraries to be multiplexed together for
efficient sequencing. Multiplexed libraries (18 samples per pool)
were sequenced on a single flow cell of the NextSeq550 DNA
Analyzer (Illumina) to generate a total of∼28million 75 bp single
reads for each sample.
Bioinformatics
Differentially expressed genes (up- and downregulated) between
SAL and PNO, SAL and IUO, and PNO and IUO were chosen
for further functional characterization using ClueGO plug-in
module (Bindea et al., 2009) in Cytoscape software (Shannon
et al., 2003). The “biological process” option in Clue-Go analysis
was used to visualize the categories of DEG functions in
each comparison.
Von Frey
Von Frey experiments were conducted (n = 4) from each group
at P17, and the same animals were tested at P75. The test was
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commenced as the rats placed four paws comfortably on the
mesh floor and the plantar were clearly visible. The examiner
randomly picked the left or right hind paw as the first evaluated
paw during each assessment. A monofilament Von Frey hair
was applied exactly vertical on the plantar surface until the hair
buckled and the shape of the hair was held for 5 s. The specific
value of the forces chosen were: 0.6, 1.0, 1.4, 2.0, 4.0, 6.0, 8.0,
10.0, and 15.0 g. The cut-off force was set as 15.0 g because the
paw would be lifted if the next force (26.0 g) was applied. During
the measuring process, each force was applied 10 times with an
interval of at least 5 s to allow the animal to recover from the
previous stimuli. Noxious responses were determined if any of
the following robust reflex responses occurred: paw retracting,
paw withdrawal, or paw licking. Once there were 4 positive
responses in 10 applications, the force was determined as the
mechanical withdrawal threshold. The mechanical withdrawal
threshold for both of two paws was recorded.
Statistical Analyses
All data represented in the manuscript are reported as mean
± SEM. Data in each analysis were normally distributed.
Significant differences were computed using Welch’s t-test
(Electrophysiology) and two-way ANOVA (Von Frey and
MRI/MRS data) followed by Tukey’s test with a significance
criterion of p ≤ 0.05. All statistical tests were performed with
GraphPad Prism (La Jolla, CA, USA); data represented as Mean
± SEM on the graphs.
RESULTS
Quantitation of Metabolites in
Oxy-Exposed Pups
Brain metabolites are spatiotemporally regulated during
development (Miyazawa and Aulehla, 2018). However, it
is unknown whether IUO or PNO exposure influences
the expression levels of these metabolites in the offspring.
Accordingly, we conducted 1H-MRS scans on the brain
hippocampus of postnatal day 17 (P17) saline, PNO, and IUO
groups (Figure 1). We found that IUO or PNO treatment did
affect metabolite concentrations in these animals [Metabolite:
F(13,208) = 96.75, P < 0.0001; Treatment: F(2,208) = 5.520,
P = 0.0046; Interaction: F(26,208) = 2.093, P = 0.0023].
Specifically, we identified higher levels of neurotransmitter
aspartate (ASP) and glutamate (GLU) in both PNO and IUO
groups. However, N-acetyl aspartate (NAA), the second most
abundant metabolite in the brain, was significantly elevated in
the IUO group. Additionally, taurine (TAU) concentration was
elevated in the PNO group but was significantly lower in the
IUO offspring compared to controls. Together, these data point
to alterations in key metabolite levels in both the PNO and IUO
groups that are more pronounced in the latter.
Synaptic Alterations in IUO and PNO
Offspring
CA1 synapses were monitored in hippocampal slices of control,
PNO, and IUO rats (Figure 2). Input-response curves showed
that the post-synaptic currents in the PNO group cells were
smaller than control (p = 0.02, p = 0.017; Figure 2A).
Although the AMPA/NMDA ratio in PNO rats appeared
reduced compared to controls, the difference was not significant
(p = 0.07; Figure 2A). The paired pulse ratio (PPR) of post-
synaptic currents did not significantly differ among the three
groups, suggesting no change in presynaptic vesicle release
probability (Figure 2A). When measuring miniature excitatory
post-synaptic currents (mEPSCs), we found that, although the
frequency and amplitude of the currents did not differ between
groups, the PNO mEPSCs had slightly faster decay kinetics
(p = 0.0048; Figure 2B), which is consistent with altered AMPA
receptor subunit composition. Together, these data point to
altered synaptic maturation in the PNO offspring.
RNA-Seq Highlights Gene Expression
Changes in Oxy-Exposed Pups
To further understand the molecular causes associated
with changes in synaptic currents, we performed RNA-
seq analysis on the prefrontal cortex (PFC) (Figure 3A;
Supplementary Table 2). Employing a criteria of 1.5-fold change
and p < 0.05, we found 62 genes (20 up and 42 down) between
saline and PNO and 161 genes (78 up and 83 down) between
saline and IUO. When comparing the PNO and IUO groups,
we found 1,465 genes (1,199 up and 266 down). We found three
genes (Sytl2—Synaptotagmin-like 2, Vwa5b1—Von Willebrand
Factor A Domain-Containing Protein 5B1, and a predicted
gene AABR07042623.1) were differentially regulated among all
three groups.
Next, the enriched biological pathways associated with
these differentially expressed proteins were determined using
Clue-GO analysis (Figure 3B; Supplementary Table 3). Notably,
pathways involved in synaptic transmission and morphine,
nicotine, and alcohol addictions were significantly enriched in
the two treatment groups. Furthermore, the opioid signaling
pathway was affected in the PNO and IUO offspring. A
number of the genes affected in the IUO and PNO pups
were associated with diseases and psychotic disorders (Table 1;
Supplementary Table 4). To summarize, oxy exposure can
significantly affect neurodevelopment in exposed offspring
by inducing changes in key genes and pathways during
synaptogenesis that could persist during late adolescence
and adulthood.
Pain Sensitivity in Oxy-Exposed Pups
One key pathway we identified from our RNA-Seq analysis
was regulation of sensory perception of pain. Because oxy is
prescribed for pain management, we investigated whether PNO
or IUO exposure has lasting effects on pain sensitivity. Von
Frey testing was conducted at P17 (pups exposed to oxy via
the breastmilk) and on the same animals at P75 (adulthood)
after a sustained absence of oxy exposure (Figure 4). While no
significant differences in the pain threshold were observed in
the PNO or IUO at P17, both groups displayed a significantly
lower pain threshold than controls at P75 [Age: F(3,242) = 455.3,
P < 0.0001; Treatment: F(2,242) = 88.13, P < 0.0001; Interaction:
F(6,242) = 31.18, P < 0.0001]. These data suggest a lasting impact
of early life oxy exposure on pain sensitivity during adulthood.
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FIGURE 1 | Metabolite concentrations in the hippocampus measured by 1H-MRS at P17 in PNO and IUO animals. Measured metabolites included Alanine (ALA),
Aspartate (ASP), Creatine (CRE), Gamma-Aminobutyric acid (GABA), Glucose (GLC), Glutamine (GLN), Glutamate (GLU), Glycine (GLY), Lactate (LAC), Myo-inositol
(MYO), N-Acetyl Aspartate (NAA), Phosphorylcholine (PC), Taurine (TAU), and total choline (tCHO). In all groups, n = 6 for all metabolites except Lac (n = 4 in the IUO
group). All data represented as mean ± SEM. *p < 0.05, **p < 0.01, ****p < 0.0001.
DISCUSSION
While previous studies have reported poor neurodevelopmental
outcomes in offspring exposed to opioids (Davis et al.,
2010; Devarapalli et al., 2016; Sithisarn et al., 2017; Fan
et al., 2018), a comprehensive analysis comparing changes in
neurodevelopment with pre- and post-natal exposure to drugs
has not been evaluated. In the present study we show for the first
time a comparative analysis on alterations in metabolic, synaptic,
molecular, and behavioral changes in offspring exposed to the
oxy pre- and post-natally. As mentioned in our previous works,
the PNO and IUO groups are clinically relevant (Shahjin et al.,
2019; Odegaard et al., 2020). The use of both PNO and IUO
groups in this study was critical to elucidate the extent of oxy
exposure effects on neonates. While the PNO group was exposed
to oxy only via the breastmilk, the IUO group was exposed via
placental concentrations of oxycodone throughout gestation as
well as via the breastmilk. Oxy as a postoperative analgesic has
been reported in the literature for postpartum pain or caesarian
sections in lieu of morphine drips (Niklasson et al., 2015; Nie
et al., 2017). It is important to note that offspring exposed to oxy
via the breastmilk may receive <10% of a typical oral therapeutic
infant dose (0.1–0.2 mg/kg) (Seaton et al., 2007). Despite this
low dose, infant exposure to oxy via the breastmilk has been
associated with sedation and central nervous system depression
(Lam et al., 2012), and a number of animal studies have also
revealed deficits in behavior and development associated with
perinatal opioid exposure (Davis et al., 2010; Devarapalli et al.,
2016; Sithisarn et al., 2017; Fan et al., 2018).
The effects of pre- and post-natal oxy use on brain chemistry
have not been clearly elucidated. Accordingly, we used 1H-
MRS to investigate the biochemical changes present in the
hippocampus of P17 rats in the PNO and IUO groups,
revealing significant alterations in key brain metabolites in
these groups. The IUO group had higher concentrations for
the neurotransmitters ASP and GLU compared to controls and
higher concentrations of NAA compared to controls and PNO.
The IUO group also had lower concentrations of TAU than
controls. GLU and ASP regulate a majority of the excitatory
synaptic neurotransmission in the brain (Ballini et al., 2008),
and their enhanced expression may point to excitotoxicity and
possibly enhanced excitatory signaling in the brain. Additionally,
higher concentrations of ASP may suggest more ASP is available
to react with acetyl-CoA to make NAA (Hajek and Dezortova,
2008), which was also elevated in the IUO group. Interestingly,
TAU plays a key role in brain development, and its deficiency
can lead to a delay in cell differentiation and migration in certain
brain areas such as cerebellum, pyramidal cells, and visual cortex
(Ripps and Shen, 2012). Further, Hernandez-Benitez et al. have
shown that TAU promotes neural development in the embryonic
brain as well as in adult brain regions (Hernández-Benítez et al.,
2010). The lower levels of TAU we observed may point to
neurodevelopmental deficits. Intriguingly, we have shown that
both IUO and PNO animals display an overall reduction in the
head size circumference (Odegaard et al., 2020), which may be
attributed in part to lower concentration of TAU.
Based on the observation of increased GLU levels in our MRS
study, we investigated the extent of synaptic changes in IUO
and PNO animals. Glutamate receptors play a role in mediating
the reward pathway involved in drug addiction (D’Souza,
2015), and they are also involved in opiate-induced neural
and behavioral plasticity (Jackson et al., 2000; Trujillo, 2000;
Zhu and Barr, 2004). AMPA receptors, one type of ionotropic
glutamate transporter, are crucial for opioid withdrawal during
development (Jakowec et al., 1995a,b; Fitzgerald et al., 1996;
Washburn et al., 1997; Mahanty and Sah, 1998; Ozawa et al.,
1998). While we saw a reduction in the AMPA/NMDA ratio in
the PNO rats, the difference was not significant. Additionally,
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FIGURE 2 | Evoked EPSC and mEPSC monitored in hippocampal slices of control, PNO, and IUO rats. (A) Evoked EPSC data; Top: A series of EPSCs recorded in
each of the three treatment conditions in response to a series of stimulus strengths (50–225 µA). Stimulus timing is marked above the traces. Group data show the
intensity-response profiles for cells recorded from Saline, PNO, and IUO rats. Middle: AMPA receptor and NMDA receptor-mediated EPSCs recorded by
voltage-clamping CA1 pyramidal cells at −70 and +40mV, respectively. The AMPA receptor component was measured at the peak of the inward EPSC while the
NMDA receptor component was measured 50ms post-stimulus. Group data of AMPA/NMDA ratios show there was no significant difference between the groups.
Bottom: Paired pulse traces showing the characteristic synaptic facilitation in response to a pair of pulses separated by 50ms. Group data show the paired pulse ratio
was not significantly different between treatment conditions. (B) Traces of mEPSCs recorded in the absence of stimulation followed by mEPSCs waveforms from
individual cells. These were obtained by averaging all detected events in individual cells. Group data show that mEPSC amplitudes and frequencies were not
significantly different between treatment groups. Group data of mEPSC decay time constants (τdecay), show that mEPSCs in the PNO group decayed more quickly
than in control. Sample sizes of recorded cells are shown in the bars of each graph; all data represented as mean ± SEM.
there were no differences in the PPR of post-synaptic currents,
suggesting no changes in vesicle release. Intriguingly, PNO
mEPSCs had slightly faster decay kinetics, which is consistent
with altered AMPA receptor subunit composition. Interestingly,
no significant effects were seen in the IUO group. Possible
reasons include the potential loss of neurons given the longer
exposure to oxy (Hu et al., 2002; Hauser and Knapp, 2017) and
the higher glutamate levels in the IUO pups compared to the
PNO group, as evidenced by 1H-MRS. Thus, our study for the
first time lends insight into the synaptic changes associated with
PNO exposure and its effects on altered glutamatergic signaling.
Recent studies employing high-throughput technologies have
further provided new inroads in elucidating the molecular
underpinnings associated with long term oxy dependency. These
include alterations in key genes associated with integrated
stress response in the brain (Fan et al., 2015), induction of
apoptotic signaling in neurons by promoting demyelination
(Fan et al., 2018), alterations in reward related genes (Zhang
et al., 2018), axon guidance molecules (Yuferov et al.,
2018), inflammation/immune-related genes (Zhang et al.,
2017), neurotransmitter receptor genes (Zhang et al., 2014),
and synaptic plasticity genes (Zhang et al., 2015), including
key sex-specific neuroplasticity-related genes (Randesi et al.,
2018). Similarly, our RNA-seq data showed alterations in
pathways associated with synaptic transmission, axon guidance,
inflammasomes, and genes associated with the reward system.
Among others, genes affecting synaptic transmission and axon
development included Egfr, Adrb2, and Ntrk. Interestingly,
Fan et al. found that chronic oxy exposure leads to axonal
degeneration in rat brains (Fan et al., 2018). Chronic oxy
exposure altered the white matter of the rats via deformation of
axonal tracks, reduced size of axonal fascicles, loss of myelin basic
protein, and accumulation of the amyloid precursor protein (Fan
et al., 2018). Importantly, human studies of infants prenatally-
exposed to opioids have shown alterations in the white matter,
such as punctate white matter lesions or white matter signal
abnormalities on structural MR imaging (Walhovd et al., 2012;
Merhar et al., 2019). The results from our RNA-seq analysis
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FIGURE 3 | Alterations in gene expression revealed by RNA-seq. (A) Differentially expressed genes at P14 identified using RNA-Seq. RNA was isolated from the PFC
regions of P14 brains (n = 6) for each group. (B) Mapping of biological processes in the PFC. Clue-Go pie diagrams resulting from RNA-seq data show enriched
biological processes involved in developmental, neurological, and psychological disorders, which are more impacted in the IUO offspring. The asterisks represent the
group term p-value representing each category. *p < 0.05, **p < 0.01.
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TABLE 1 | Differentially expressed genes identified in PFC from both IUO and
PNO groups that are related to diseases or psychotic disorders.
Disease or psychotic
disorder
Genes associated with the
disorder







Clinical depression ITGAL, NPY












Manic symptom DNAH8, NR3C2, CSRP1
Non-organic psychosis OPRM1, TBX1, CDH17, PDE10A,
CSNK1E, DLX1, SP8, SP3
Paranoid schizophrenia NTRK2
Psychoses, drug DPYSL2, DRD1
Recurrent depression DRD1, DRD3
Schizoaffective disorder GRIA1, NPY, PCDH11Y, GABRB1
Schizophrenia, catatonic CELSR1





A criterion of ±1.5-fold change, p < 0.05, and FDR < 5% was used.
align with these previous observations from both animal models
and human studies. Interestingly, our RNA-seq data showed
differences in glutamatergic synapse genes, with seven genes
being differentially expressed in the IUO and PNO groups:
Adrb2, Egfr, Grik2, Npy2r, Ntrk1, Ntrk2, and Oxtr. Combined
with our electrophysiology results, our RNA-seq results further
suggest alterations in glutamatergic signaling within the reward
pathway of these exposed offspring. In addition, our studies
suggest PNO and IUO exposure not only alter gene expression
but also may increase the risk of developing other diseases,
particularly renal disease. Genes associated with renal adysplasia,
renal cancers, renal failure, and several other renal diseases
were differentially regulated in the PNO and IUO groups.
Interestingly, depletion of TAU, such as that reported in our
IUO group MRS data, has been shown to play a role in renal
dysfunction (Ripps and Shen, 2012). In human studies, opioid
use has been associated with acute kidney injury, particularly in
the case of opioid overdose (Mallappallil et al., 2017). The altered
gene expression and lower levels of TAU in the reward system
of the IUO offspring during early development may warrant
FIGURE 4 | Measurement of pain thresholds using the Von Frey test. Animals
from each group (n = 4) were tested at P17 and again at P75 to determine
changes in pain thresholds. At P75, the oxy-exposed groups had lower pain
thresholds than controls. Additionally, IUO pups had lower pain thresholds
than PNO pups. All data represented as mean ± SEM. ***p < 0.001, ****p <
0.0001.
further exploration into the potential of these offspring to develop
renal diseases as adults. Further, several genes in our analysis are
also involved in other substance use-related disorders, such as
nicotine, cocaine, and cannabis dependence,morphine addiction,
and fetal alcohol spectrum disorders. Opioid use has also been
associated with mental health disorders, with a higher proportion
of adolescents exposed prenatally to opioids having experiences
with major depressive episodes, alcohol abuse, and attention
deficit hyperactivity disorder (Nygaard et al., 2019). Genes
associated with depression, anxiety disorders, schizophrenia, and
obsessive compulsive disorder were all enriched in both PNO
and IUO offspring, suggesting a higher risk for such disorders
in these offspring.
Oxy is generally prescribed for pain management, and the
enrichment of the sensory pain pathway from our RNA-
Seq analysis was not surprising. When assessed by the
Von Frey filament test at P17, the PNO and IUO pups
did not exhibit a difference in pain threshold compared
to saline controls. However, during adulthood (P75), these
same animals, especially the IUO group, displayed significantly
lower pain threshold compared to saline offspring. In a study
of neonatal morphine exposure, P40 rats exhibited a lower
pain threshold than the controls, but the pain threshold
approached control levels by P50 when tested using Von
Frey (Zhang and Sweitzer, 2008). Because we see similar
results continuing up to P75, pre- and post-natal exposure
to oxy may alter normal synaptic development involved in
nociception. Indeed, a number of genes shown to be differentially
regulated in both PNO and IUO in our RNA-seq data are
associated with pain: Adrb2, Cck, Htr2c, Npy2r, Oprk1, Oprm1,
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and P2rx3. Further analyses of these genes could possibly
lend more mechanistic insights into the pain etiology in
these offspring.
In summary, our study using a holistic systems approach
shows a comparative analysis on alterations in metabolic,
synaptic, molecular, and behavioral changes in offspring exposed
to the prescription opioid oxy pre- and post-natally. Importantly,
these changes not only impact the overall development during
early stages but also persist into adulthood.
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